By Lauren Tara LaCapra NEW YORK (Reuters) – Goldman Sachs Group Inc received $ 32.5 million for its remaining stake in Epocrates Inc, after the healthcare technology company was acquired by athenahealth Inc , according to a securities filing on Friday. Goldman had originally acquired 3 million shares in Epocrates for $ 40 million in 2007, as part of its plan to build out an independent-research arm called Hudson Street. The business sold institutional investors information from a variety of firms that collected data and performed market analysis. …
There are no comments yet. Why not be the first to speak your mind.